Abstract: Disclosed herein are anti-GM-CSF antibodies capable of binding to human GM-CSF and blocking its biological activities. Also provided herein are pharmaceutical compositions comprising the anti-GM-CSF antibodies and therapeutic and diagnostic uses of such antibodies.

Abstract: An adsorption assembly and a battery are provided. The adsorption assembly includes: a housing including a gas permeable portion; and an adsorbent encapsulated by the housing. The adsorption assembly can effectively isolate the adsorbent from the external environment by providing the housing, thereby preventing the adsorption performance of the adsorbent from being affected, and the housing includes a gas permeable portion, which can make the produced gas in the external environment enter the housing and be effectively adsorbed by the adsorbent. In particular, when the adsorbent is used for a battery, especially a soft pack battery, the gas produced inside the battery can be effectively adsorbed to prevent liquid leakage of the battery seal caused by breakage of the battery seal by gas, improving reliability and safety of the battery and extending lifetime of the battery.

Abstract: The present invention provides methods for treating hepatitis B virus (HBV) infection using antibodies which specifically bind to human IFN?.

Abstract: The present invention provides methods for treating hepatitis B virus (HBV) infection using antibodies which specifically bind to human IFN?.

Abstract: An anti-human T-cell immunoglobulin domain and mucin domain 3 (TIM-3) antibody, can bind the peptides, comprising the amino-acid sequence RKGDVSL (SEQ ID NO: 9) and/or EKFNLKL (SEQ ID NO: 10) of human TIM-3 protein. The antibody can regulate immune cell activity. The antibody or binding fragment thereof is useful in diagnosis, prognosis, and treatment of cancers that have been reported to express cell-surface TIM-3 such as lung, liver, esophageal cancer and solid tumors.

Abstract: A fan frame is provided and includes a body and a first cover plate. The body includes a main surface and a first side which is substantially perpendicular to the main surface. A first channel and a second channel, which are adjacent to each other, are formed in the body, and a first space is formed among the main surface, the first side, a sidewall of the first channel, and a sidewall of the second channel. The cover plate is disposed on the body, and covers the first space, wherein a first hole is formed in the first cover plate, and the first space communicates with the external environment via the first hole.

Abstract: An adsorption assembly and a battery are provided. The adsorption assembly includes: a housing including a gas permeable portion; and an adsorbent encapsulated by the housing. The adsorption assembly can effectively isolate the adsorbent from the external environment by providing the housing, thereby preventing the adsorption performance of the adsorbent from being affected, and the housing includes a gas permeable portion, which can make the produced gas in the external environment enter the housing and be effectively adsorbed by the adsorbent. In particular, when the adsorbent is used for a battery, especially a soft pack battery, the gas produced inside the battery can be effectively adsorbed to prevent liquid leakage of the battery seal caused by breakage of the battery seal by gas, improving reliability and safety of the battery and extending lifetime of the battery.

Abstract: An anti-human T-cell immunoglobulin domain and mucin domain 3 (TIM-3) antibody, can bind the peptides, comprising the amino-acid sequence RKGDVSL (SEQ ID NO: 9) and/or EKFNLKL (SEQ ID NO: 10) of human TIM-3 protein. The antibody can regulate immune cell activity. The antibody or binding fragment thereof is useful in diagnosis, prognosis, and treatment of cancers that have been reported to express cell-surface TIM-3 such as lung, liver, esophageal cancer and solid tumors.

Abstract: Methods and compositions are provided for the diagnosis and treatment of heart diseases relating to cardiac hypertrophy, and for the regulation of proliferation and differentiation of cardiomyocyte progenitors in vitro. The detection of expression of components of the BAF complex, including, without limitation, detection of expression of Brg1, provides useful methods for early detection, diagnosis, staging, and monitoring of conditions leading to hypertrophy and enlargement of the heart. Manipulation of Brg1 activity provides for therapeutic intervention in the development of cardiac hypertrophy, where methods of decreasing Brg1 activity, e.g. through inhibition of binding, decreasing expression, and the like, reduces cardiac hypertrophy.

Abstract: This invention provides different compositions extracted from Fagopyrum cymosum (Trev.) Meisn. Said compositions comprise active components for therapeutic applications. This invention also provides a method of preparation of the compositions and a method of identification and determination of individual components of said compositions. Finally, this invention provides various uses of the compositions.

Abstract: This invention provides different compositions extracted from Fagopyrum cymosum (Trev.) Meisn. Said compositions comprise active components for therapeutic applications. This invention also provides a method of preparation of the compositions and a method of identification and determination of individual components of said compositions. Finally, this invention provides various uses of the compositions.

Abstract: This invention provides different compositions extracted from Fagopyrum cymosum (Trev.) Meisn. Said compositions comprise active components for therapeutic applications. This invention also provides a method of preparation of the compositions and a method of identification and determination of individual components of said compositions. Finally, this invention provides various uses of the compositions.